ALKERMES reported 13.78 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Acadia Pharmaceuticals 16.19 4.11 Jun/2025
ALKERMES 13.78 1.23 Jun/2025
Amgen 12.51 28.7 Jun/2025
Biogen 12.41 0.17 Jun/2025
BioMarin Pharmaceutical 15.13 7.26 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Eli Lilly 37 7.55 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 19.02 9.62 Jun/2025
Malin Corporation 11.81 0.72 Jun/2023
Merck 8.58 4.74 Jun/2025
Neurocrine Biosciences 42.61 5.9 Jun/2025
Otsuka Holdings 8.89 21.88 Jun/2025
Pfizer 9.12 8.86 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Vertex Pharmaceuticals 27.81 3.5 Jun/2025